Page last updated: 2024-11-02

phenoxybenzamine and Hematologic Diseases

phenoxybenzamine has been researched along with Hematologic Diseases in 2 studies

Phenoxybenzamine: An alpha-adrenergic antagonist with long duration of action. It has been used to treat hypertension and as a peripheral vasodilator.

Hematologic Diseases: Disorders of the blood and blood forming tissues.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
JAGANNATHAN, SN1
SRIKANTIA, SG1
GOPALAN, C1
Yamazaki, H1
Sano, T1
Odakura, T1
Takeuchi, K1
Matsumura, T1
Hosaki, S1
Shimamoto, T1

Trials

1 trial available for phenoxybenzamine and Hematologic Diseases

ArticleYear
Appearance of thrombogenic tendency induced by adrenaline and its prevention by -adrenergic blocking agent, nialamide and pyridinolcarbamate.
    Thrombosis et diathesis haemorrhagica, 1971, Oct-31, Volume: 26, Issue:2

    Topics: Administration, Oral; Blood Cell Count; Blood Coagulation; Blood Coagulation Tests; Blood Platelets;

1971

Other Studies

1 other study available for phenoxybenzamine and Hematologic Diseases

ArticleYear
Hypocholesteremic effect of phenoxybenzamine (dibenzyline), an adrenergic blocking agent. Experimental studies with monkeys and human volunteers.
    Circulation research, 1962, Volume: 11

    Topics: Adrenergic Antagonists; Animals; Cholesterol; Haplorhini; Healthy Volunteers; Hematologic Diseases;

1962